Inspiring Results For Phase III Disease-Modifying Cystic Fibrosis Drug

Inspire Pharmaceuticals' denufosol showed improvement in FEV1 versus placebo over 24 weeks.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet